FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/08/2026
Voltar para busca
Dado oficial do USPTO
METEOR BIOTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
METEOR BIOTECH
ST13
US500000079411347Classe
5, 9, 42, 44
Pedido
79411347
Registro
8090562
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42, 44
Data de depósito
29/05/2024
Data de registro
06/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/01/2026
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
MILMOE, MAUREEN H
Unidade examinadora
M20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Meteor Biotech Co., Ltd.
Representantes
Minchul Yang STIP Law Group, LLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Reagents for medical use; Drugs for medical purposesacetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testing
Classe 9
Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencingnot for medical purposes; Laboratory devices for analyzing polynucleic acidnot for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genesnot for medical purposes; DNA chips; Laboratory apparatus and instruments for preparing nucleic acid samples; Laboratory apparatusdevices for analyzing protein sequencesnot for medical purposes; Plates having multi-well arrays for analyzing genes for laboratory research use
Classe 42
Biomarker discovery services being medical research; Custom design and development of equipment for manufacturing pharmaceuticals; Biological laboratory services relating to the selection and screening of biomarkers in biological tissue samples for scientific research purposes; Design and development of equipment for selection and screening of biomarkers in in biological tissue samples; Scientific research for medical purposes in the area of cancerous diseases; Consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support servicestroubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing services for medical research purposes
Classe 44
Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removaltreatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer preventionscreeningdiagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling for medical purposes; Medical analysis services of biomarkers for diagnostic purposes provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/07/2026
FIMP
FINAL DISPOSITION PROCESSED
15/07/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
21/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/11/2025
PUBO
PUBLISHED FOR OPPOSITION
18/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/10/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/09/2025
GNFR
FINAL REFUSAL E-MAILED
29/09/2025
CNFR
FINAL REFUSAL WRITTEN
29/09/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/07/2025
GNSL
LETTER OF SUSPENSION E-MAILED
05/07/2025
CNSL
SUSPENSION LETTER WRITTEN
05/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2025
RFNT
REFUSAL PROCESSED BY IB
17/01/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/01/2025
RFRR
REFUSAL PROCESSED BY MPU
02/01/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/12/2024
CNRT
NON-FINAL ACTION WRITTEN
13/12/2024
DOCK
ASSIGNED TO EXAMINER
10/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/12/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace METEOR BIOTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.